Trading symbol: TSX-V-NEX: ENTH.H
VANCOUVER, BC, Sept. 7, 2021 /CNW/ - Entheos Capital Corp. (the
"Company"), announces that, further to its press releases dated
February 11, 2021 and June 25, 2021, it has received the conditional
approval of the CSE for the listing of its common shares following
completion of its proposed reverse takeover transaction (the
"Transaction") with The BC Bud Corporation ("BCBC"). Subject to the
Company fulfilling the CSE's listing requirements. The common
shares are expected to trade under the ticker symbol "BCBC"
following a change of the Company's name to 'The BC Bud
Corporation'.
In addition, the Company received approval for the Transaction
from Company's minority shareholders at the annual and special
meeting of shareholders held on July 29,
2021. The Company has also applied to delist its common
shares from the NEX Exchange in advance of the Transaction, with
such delisting anticipated to take effect immediately prior to the
closing of the Transaction, which is currently anticipated to occur
within the next 10 days.
As previously announced, pursuant to the Transaction, the
Company will issue 26,250,000 common shares in its capital to the
holders of common shares in the capital of BCBC by way of share
exchange.
Further details of the Transaction are set out in the Company's
information circular dated June 21,
2021, a copy of which is available under the Company's SEDAR
profile at www.sedar.com.
Information Concerning BCBC
BCBC is incorporated under the laws of Canada and is an early-stage company pursuing
premium recreational cannabis products in the cannabis industry
through licensing, manufacturing and joint venture agreements with
licensed producers under the Cannabis Act. BCBC is a not a
licensed producer. Its expected branded products will include The
BC Bud Corporation flower products, edibles under the brand 'Canna
Beans', concentrates sold as Solventless Solutions, 'Buds'
beverages line and select lifestyle apparel.
Trading Halt
The Company's shares continue to be halted from trading and are
expected to remain halted pending completion of the Transaction.
Trading of the Company's shares will not resume on the NEX and will
only re-commence upon listing with the CSE.
Forward-Looking Statements
This news release contains certain "forward looking statements"
including, for example, statements relating to the completion of
the Transaction. Such forward-looking statements involve
risks and uncertainties, both known and unknown. The results
or events depicted in these forward-looking statements may differ
materially from actual results or events. In addition to
other factors and assumptions which may be identified herein,
assumptions have been made regarding and are implicit in, among
other things: receipt of regulatory approvals, the Company's
ability to complete the Transaction, the state of the capital
markets, the impact of the COVID-19 pandemic, the ability of the
Company to successfully manage the risks inherent in pursuing
business opportunities in the cannabis industry, and the ability of
the Company to obtain qualified staff, equipment and services in a
timely and cost efficient manner to develop its business. Any
forward-looking statement reflects information available to the
Company as of the date of this news release and, except as may be
required by applicable securities laws, the Company disclaims any
intent or obligation to update any forward-looking statement,
whether as a result of new information, future events or results or
otherwise.
Entheos Capital Corp.
"Brayden R.
Sutton"
_______________________________________
Brayden
R. Sutton, Chief Executive Officer
Neither the TSX Venture Exchange nor its Regulation
Services provider (as that term is defined in the policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Completion of the Transaction is subject to a number of
conditions. There can be no assurance that the Transaction will be
completed as proposed or at all. Investors are cautioned that,
except as disclosed in the Information Circular and Listing
Statement to be prepared in connection with the Transaction, any
information released or received with respect to the Transaction
may not be accurate or complete and should not be relied upon.
Trading in the securities of the Company should be considered
highly speculative. The TSX Venture Exchange has in no way passed
upon the merits of the proposed transaction and has neither
approved nor disapproved the contents of this press release
SOURCE Entheos Capital Corp.